A detailed history of Richard P Slaughter Associates Inc transactions in Moderna, Inc. stock. As of the latest transaction made, Richard P Slaughter Associates Inc holds 23,718 shares of MRNA stock, worth $1.43 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares
23,718
Previous 24,448 2.99%
Holding current value
$1.43 Million
Previous $2.61 Million 8.1%
% of portfolio
0.75%
Previous 0.71%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 10, 2024

SELL
$101.21 - $166.61 $73,883 - $121,625
-730 Reduced 2.99%
23,718 $2.82 Million
Q1 2024

Apr 09, 2024

SELL
$85.37 - $115.44 $474,230 - $641,269
-5,555 Reduced 18.51%
24,448 $2.61 Million
Q4 2023

Jan 08, 2024

BUY
$69.51 - $104.43 $697,602 - $1.05 Million
10,036 Added 50.26%
30,003 $2.98 Million
Q3 2023

Oct 10, 2023

BUY
$96.41 - $126.61 $381,976 - $501,628
3,962 Added 24.75%
19,967 $2.06 Million
Q2 2023

Jul 06, 2023

BUY
$118.5 - $160.53 $32,706 - $44,306
276 Added 1.75%
16,005 $1.94 Million
Q1 2023

Apr 18, 2023

SELL
$135.66 - $197.02 $26,725 - $38,812
-197 Reduced 1.24%
15,729 $2.42 Million
Q4 2022

Jan 09, 2023

SELL
$118.38 - $210.04 $2,722 - $4,830
-23 Reduced 0.14%
15,926 $0
Q3 2022

Oct 11, 2022

BUY
$118.07 - $194.18 $228,347 - $375,544
1,934 Added 13.8%
15,949 $1.89 Million
Q2 2022

Jul 08, 2022

BUY
$117.13 - $176.59 $15,578 - $23,486
133 Added 0.96%
14,015 $2 Million
Q1 2022

Apr 11, 2022

BUY
$126.46 - $235.05 $403,660 - $750,279
3,192 Added 29.86%
13,882 $2.39 Million
Q4 2021

Jan 13, 2022

BUY
$225.82 - $368.51 $1.28 Million - $2.08 Million
5,656 Added 112.36%
10,690 $2.72 Million
Q3 2021

Oct 06, 2021

SELL
$221.9 - $484.47 $2 Million - $4.38 Million
-9,034 Reduced 64.22%
5,034 $1.94 Million
Q2 2021

Jul 12, 2021

BUY
$129.91 - $234.98 $1.83 Million - $3.31 Million
14,068 New
14,068 $3.31 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $23.6B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Richard P Slaughter Associates Inc Portfolio

Follow Richard P Slaughter Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Richard P Slaughter Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Richard P Slaughter Associates Inc with notifications on news.